Eumycetoma: A Peruvian case series

Bustamante, Beatriz; Oyarce, James; Campos, Pablo E.

dc.contributor.author	Bustamante, Beatriz
dc.contributor.author	Oyarce, James
dc.contributor.author	Campos, Pablo E.
dc.date.accessioned	2022-11-20T21:44:46Z
dc.date.available	2022-11-20T21:44:46Z
dc.date.issued	2019
dc.identifier.citation	Bustamante, B., Oyarce, J. & Campos, P. E. (05 de setiembre, 2019). Eumycetoma: A Peruvian case series. [Presentación de póster]. XXII Jornadas Científicas 2019 “Dr. Eduardo Pretell Zárate”, Lima, Peru.
dc.identifier.uri	https://hdl.handle.net/20.500.12866/12696
dc.description.abstract	Objective: To report the epidemiological and clinical characteristics of eumycetoma patients diagnosed in a referral tertiary hospital of Lima-Peru. Methods: Patients with a diagnosis of eumycetoma evaluated at the Cayetano Heredia Hospital between 2000 and 2017. Diagnosis of eumycetoma required demonstration of grains at clinical or histopathological examination. Epidemiological and clinical data was extracted from clinical and mycology laboratory records. The isolates were identified on the basis of cultural and morphological characteristics. When it was possible a molecular diagnostic test was used for the identification of the species. Results: 19 eumycetoma patients were diagnosed, most of them were males, median age of 37. The median duration of disease was 65 months, and eleven out of 14 patients reported history of agricultural activity before the onset of the disease. Most patients were residents of two regions, Piura and Lambayeque. Lesions were located on the foot in 17 patients, on the leg in one patient and on the hand in another patient. 17 patients had the classic clinical triad. Ten out of 15 patients with imaging evaluation presented bone lesions. Among 17 patients with presence of macroscopic grains, 12 were black and 5 were white-yellowish grains. In the other two patients, the presence of grains was only evidenced in the histopathology. Ten of the 12 patients with black grain eumycetoma acquired the disease in the regions of Lambayeque and Piura. The etiological agent was isolated in 12 patients; Madurella mycetomatis in eight, Fusarium spp in two, Scedosporium apiospermum specie complex in one, and Phaeoacremonium sphinctrophorum in another patient. Most patients received itraconazole for treatment. Conclusion: In Peru, eumycetoma patients are diagnosed lately, when disease has already reached an advanced stage. Limited data suggest that eumycetoma acquisition in Peru occurs mainly in arid and sandy areas of northern regions.
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	Universidad Peruana Cayetano Heredia
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/
dc.subject	Eumycetoma
dc.subject	case series
dc.subject	Peru
dc.title	Eumycetoma: A Peruvian case series
dc.type	info:eu-repo/semantics/conferenceObject
dc.description.conferenceDate	2019-09-05
dc.relation.conference	XXII Jornadas Científicas 2019 “Dr. Eduardo Pretell Zárate”